Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01475890 · ClinicalTrials.gov registry record · Phase 2
Vitamin D Supplementation in HIV
A Phase 2 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 2
- Development phase
- 58
- Enrollment target
NCT01475890 is a Phase 2 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 58 participants.
The verdict
NCT01475890, a Phase 2 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 58 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate safety and efficacy of vitamin D supplementation in children, adolescents and young adults with Human Immunodeficiency Virus and acquired immunodeficiency syndrome (HIV/AIDS). The study is a 12-month randomized, double blind, placebo-controlled study of vitamin D3 (vit D) supplementation using 7000IU/day based on evidence from the Vit D Dose Finding Study-IRB 09-007332.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2011-07 |
| Est. Completion | 2017-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01475890
The ClinicalTrials.gov registry entry for NCT01475890 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01475890 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01475890 about?
NCT01475890 is a clinical study titled "Vitamin D Supplementation in HIV". The purpose of this study is to evaluate safety and efficacy of vitamin D supplementation in children, adolescents and young adults with Human Immunodeficiency Virus and acquired immunodeficiency syndrome (HIV/AIDS). The study is a 12-month randomized, double blind, placebo-controlled study of vitam...
What is the current status of trial NCT01475890?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 58 participants. The study started on 2011-07. Estimated completion is 2017-02.
What interventions are being tested in trial NCT01475890?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Vitamin D3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01475890?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.